Showing 1 posts of 1 posts found.
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection